In summary, methods have now been established for a more comprehensive examination of the role brain glycolipids play in the immunopathogenesis of MS. Further studies will address the frequency of glycolipid reactive T cells in blood and CSF of MS and other neurological disease controls with possible correlations to antiglycolipid antibody levels.